verapamil has been researched along with Menopause in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A clear reduction of BP values was recorded after both the first and the second month of treatment with kanrenoate, with the maximal effect obtained when the dosage titration at 100 mg/day was accomplished." | 5.35 | Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients. ( Blengio, GS; Ciacciarelli, A; Corrocher, R; Falcone, S; Olivieri, O; Pizzolo, F; Signorelli, D, 2008) |
| "Women with migraine often experience a worsening of symptoms at menopause." | 2.39 | Approach to the patient with migraine. ( Baringer, JR; Raskin, NH, 1996) |
| "A clear reduction of BP values was recorded after both the first and the second month of treatment with kanrenoate, with the maximal effect obtained when the dosage titration at 100 mg/day was accomplished." | 1.35 | Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients. ( Blengio, GS; Ciacciarelli, A; Corrocher, R; Falcone, S; Olivieri, O; Pizzolo, F; Signorelli, D, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olivieri, O | 1 |
| Pizzolo, F | 1 |
| Ciacciarelli, A | 1 |
| Corrocher, R | 1 |
| Signorelli, D | 1 |
| Falcone, S | 1 |
| Blengio, GS | 1 |
| Jankovic, SM | 1 |
| Protic, BA | 1 |
| Jankovic, SV | 1 |
| Raskin, NH | 1 |
| Baringer, JR | 1 |
| Hulthén, UL | 1 |
| Katzman, PL | 1 |
1 review available for verapamil and Menopause
| Article | Year |
|---|---|
Approach to the patient with migraine.
Topics: Analgesics, Non-Narcotic; Antipyrine; Chloral Hydrate; Drug Combinations; Drug Therapy, Combination; | 1996 |
3 other studies available for verapamil and Menopause
| Article | Year |
|---|---|
Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Female; Huma | 2008 |
Contractile effect of acetylcholine on isolated ampullar segment of Fallopian tubes.
Topics: Acetylcholine; Adult; Aged; Diamines; Fallopian Tubes; Female; Follicular Phase; Humans; Lidocaine; | 2004 |
Serum gonadotropins in postmenopausal women after long-term verapamil treatment.
Topics: Aged; Blood Pressure; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hypertension; Lut | 1989 |